
Molecular Data MKD
Quarterly report 2019-Q4
added 08-19-2023
Molecular Data Income Statement 2011-2026 | MKD
Annual Income Statement Molecular Data
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | 6.95 B | 13.6 B | 127 M | 127 M | - | - | - | - | - | - |
Shares |
- | 348 M | 311 M | 311 M | 311 M | - | - | - | - | - | - |
Historical Prices |
2.31 | 19.9 | 43.8 | - | - | - | - | - | - | - | - |
Net Income |
- | -328 M | -194 M | -255 M | -108 M | -114 M | - | - | - | - | - |
Revenue |
- | 7.6 B | 13.2 B | 9.05 B | 4.2 B | 3.21 B | - | - | - | - | - |
Cost of Revenue |
- | 7.61 B | 13.1 B | 8.97 B | 4.15 B | - | - | - | - | - | - |
Gross Profit |
- | -10.2 M | 101 M | 80.2 M | 50.2 M | 26.1 M | - | - | - | - | - |
Operating Income |
- | -332 M | -192 M | -236 M | -91.2 M | - | - | - | - | - | - |
Interest Expense |
- | 10.7 M | 4.37 M | 19 M | 16.8 M | - | - | - | - | - | - |
EBITDA |
- | -331 M | -191 M | -234 M | -89.7 M | -105 M | - | - | - | - | - |
Operating Expenses |
- | 321 M | 293 M | 316 M | 140 M | 132 M | - | - | - | - | - |
General and Administrative Expenses |
- | 210 M | 104 M | 174 M | 41.7 M | 41.8 M | - | - | - | - | - |
All numbers in CNY currency
Quarterly Income Statement Molecular Data
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | - | - | - | - | - | - | - | - | 311 M | - | - | - | 311 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
The income statement is one of the three key financial reports of a company Molecular Data (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Chemicals industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Роллман
RLMN
|
- | - | - | ||
|
Куйбышевазот
KAZT
|
- | - | - | ||
|
Казаньоргсинтез
KZOS
|
- | - | - | ||
|
Celanese Corporation
CE
|
$ 62.28 | 2.38 % | $ 6.82 B | ||
|
Rayonier Advanced Materials
RYAM
|
$ 11.22 | 2.23 % | $ 749 M | ||
|
Ciner Resources LP
CINR
|
- | 0.81 % | $ 344 M | ||
|
Sociedad Química y Minera de Chile S.A.
SQM
|
$ 79.18 | 2.94 % | $ 17.5 B | ||
|
DuPont de Nemours
DD
|
$ 46.15 | 1.82 % | $ 19.3 B | ||
|
AdvanSix
ASIX
|
$ 23.33 | 1.57 % | $ 628 M | ||
|
LSB Industries
LXU
|
$ 15.55 | 0.97 % | $ 1.12 B | ||
|
Eastman Chemical Company
EMN
|
$ 70.84 | 1.25 % | $ 8.13 B | ||
|
Valhi
VHI
|
$ 14.31 | 0.39 % | $ 408 | ||
|
Methanex Corporation
MEOH
|
$ 60.02 | 2.2 % | $ 3.18 B | ||
|
FutureFuel Corp.
FF
|
$ 3.66 | -1.62 % | $ 161 M | ||
|
Huntsman Corporation
HUN
|
$ 11.88 | 4.16 % | $ 2.05 B | ||
|
Braskem S.A.
BAK
|
$ 4.23 | 0.59 % | $ 1.54 B | ||
|
Ashland Global Holdings
ASH
|
$ 52.26 | 2.87 % | $ 2.4 B | ||
|
Dow
DOW
|
$ 39.31 | 2.61 % | $ 28 B | ||
|
Minerals Technologies
MTX
|
$ 69.89 | 2.67 % | $ 2.19 B | ||
|
Adicet Bio
ACET
|
$ 6.79 | 1.42 % | $ 46.8 M | ||
|
Univar Solutions
UNVR
|
- | -0.01 % | $ 5.99 B | ||
|
Air Products and Chemicals
APD
|
$ 287.33 | 0.36 % | $ 64 B | ||
|
Tronox Holdings plc
TROX
|
$ 8.75 | 3.55 % | $ 1.39 B | ||
|
Westlake Chemical Partners LP
WLKP
|
$ 22.4 | 0.47 % | $ 790 M |